The Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
Rutgers, The State University of New Jersey
Zhejiang University
Weill Medical College of Cornell University
Northwestern University
Huazhong University of Science and Technology
Mayo Clinic
M.D. Anderson Cancer Center
Mayo Clinic